Microbial Drug Resistance
Scope & Guideline
Illuminating the Path to Effective Antimicrobial Strategies
Introduction
Aims and Scopes
- Mechanisms of Drug Resistance:
Research articles explore the genetic, biochemical, and physiological mechanisms by which bacteria and fungi develop resistance to antimicrobial agents, including beta-lactams, macrolides, and newer antibiotics. - Clinical Implications of Resistance:
The journal emphasizes studies that investigate the clinical consequences of antimicrobial resistance, including treatment failures, infection outcomes, and the implications for public health. - Surveillance and Epidemiology:
Publications include epidemiological studies that track the prevalence and distribution of resistance genes in various environments, including hospitals, communities, and animal populations. - Novel Therapeutic Approaches:
Research on new antimicrobial agents, combination therapies, and alternative treatment strategies is a key focus, showcasing efforts to combat resistance in clinical settings. - Environmental and One Health Perspectives:
The journal also covers studies that assess the environmental impact of resistant pathogens and the interconnectedness of human, animal, and environmental health in the context of antimicrobial resistance.
Trending and Emerging
- Characterization of Resistance Genes and Mobile Elements:
There is a growing emphasis on the characterization of resistance genes, particularly those located on mobile genetic elements such as plasmids, which facilitate the spread of resistance across different bacterial species. - Impact of COVID-19 on Resistance Trends:
Research examining how the COVID-19 pandemic has influenced antimicrobial resistance patterns, treatment practices, and infection control measures has gained significant attention. - Use of Advanced Genomic Techniques:
The application of whole-genome sequencing and other genomic techniques to analyze resistance mechanisms and track outbreaks is becoming increasingly prevalent in published studies. - Environmental Resistance Dynamics:
Emerging research focuses on the dynamics of antimicrobial resistance in environmental contexts, including wastewater, agricultural settings, and wildlife, highlighting the importance of a One Health approach. - Innovative Therapeutic Strategies:
There is a rising interest in exploring novel therapeutic strategies, including the use of bacteriophages, antimicrobial peptides, and combination therapies, to overcome drug resistance.
Declining or Waning
- Antibiotic Stewardship in Specific Settings:
Although antibiotic stewardship remains important, there has been a noticeable decline in studies focusing solely on stewardship practices within specific healthcare settings, as more comprehensive and integrated approaches are being adopted. - Basic Laboratory Techniques for Resistance Detection:
Research centered around traditional laboratory methods for detecting resistance, such as disk diffusion or standard broth microdilution, appears to be less frequent, as newer molecular and rapid testing methods gain traction. - Single-Pathogen Studies:
The trend has shifted towards multi-pathogen studies and broader environmental assessments, leading to a decrease in publications focusing exclusively on single-pathogen resistance profiles. - Global Surveys of Resistance Patterns:
While still relevant, the frequency of global surveys of resistance patterns has diminished, possibly due to the increasing focus on localized studies that address specific regional challenges.
Similar Journals
ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA
Exploring the frontiers of microbial interactions.ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA is a distinguished academic journal published by AKADEMIAI KIADO ZRT, focusing on significant advancements in the fields of microbiology, immunology, and infectious diseases. Established in 1994, this journal serves as a vital platform for researchers, professionals, and students keen on exploring the complexities of microbial interactions and immune responses. With a current Impact Factor reflecting its rank within the Q3 categories for Immunology, Microbiology, and Infectious Diseases, it retains a critical position in disseminating innovative research. Although not open access, the journal provides extensive insights disseminated through various academic databases, ensuring a broad reach within the scholarly community. Its convergence over three decades indicates a robust commitment to excellence in scientific inquiry and knowledge sharing. As it moves towards the future, ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA continues to uphold its legacy of fostering collaborative research initiatives that contribute to the understanding and treatment of microbial diseases globally.
Lancet Microbe
Empowering Researchers to Combat Microbial ThreatsThe Lancet Microbe is a leading peer-reviewed journal published by ELSEVIER, focused on advancing research in the fields of infectious diseases, microbiology, and virology. Since its inception in 2020, this open-access journal has rapidly achieved a prestigious reputation, evidenced by its impressive rankings in the Scopus Ranks, where it holds positions within the top 10 in multiple categories and boasts high percentiles, reflecting the impact and relevance of its published works. With a quarterly publication schedule, the Lancet Microbe aims to disseminate critical findings and foster innovation within the scientific community, providing a platform for researchers and professionals to share their significant contributions. The journal is committed to facilitating knowledge exchange and accessibility, making it an essential resource for academicians and practitioners dedicated to addressing global health challenges.
Reviews and Research in Medical Microbiology
Illuminating the Evolving Landscape of Microbial ResistanceReviews and Research in Medical Microbiology is a premier academic journal published by LIPPINCOTT WILLIAMS & WILKINS, focusing on groundbreaking research and comprehensive reviews that advance the understanding of medical microbiology. With an ISSN of 2770-3150 and an E-ISSN of 2770-3169, this journal serves as an essential resource for researchers, healthcare professionals, and students dedicated to the study of pathogens, infectious diseases, and microbial mechanisms affecting health. While the journal currently does not offer open access, its rigorous peer-review process ensures that only high-quality, impactful research is disseminated to the scientific community. The journal aims to bridge gaps in knowledge by presenting cutting-edge studies that explore novel therapeutic strategies, diagnostic methods, and the evolving landscape of microbial resistance. Nestled in the heart of Philadelphia, this journal proudly contributes to the advancement of medical microbiology and is an indispensable platform for the publication of critical findings that shape clinical practices and research trajectories in the field.
BMC MICROBIOLOGY
Empowering the global microbiology community with open access knowledge.BMC Microbiology is a leading open access journal published by BMC, dedicated to advancing the field of microbiology since its inception in 2001. With an ISSN of 1471-2180, this journal provides a vital platform for researchers, professionals, and students to share and access high-quality research and innovation in both general and medical microbiology. Based in the United Kingdom, BMC Microbiology holds a commendable Q2 ranking in both various microbiological categories according to the 2023 Scopus rankings, indicating its strong influence in the microbiological community, with a rank of #47 out of 140 in Medical Microbiology and #62 out of 182 in general Microbiology. The journal's commitment to open access ensures that groundbreaking research is freely available to facilitate collaboration and knowledge sharing among the global community of microbiologists. With a focus on publishing original research, reviews, and case studies, BMC Microbiology plays a critical role in disseminating information that can impact health and environmental conditions around the world.
mSphere
Empowering breakthroughs in the world of microorganisms.mSphere is a leading open-access journal published by the American Society for Microbiology, dedicated to the dynamic fields of Microbiology and Molecular Biology. Since its inception in 2016, mSphere has rapidly established itself as a reputable source of scholarly research, achieving notable impact factors and excellence within the academic community. The journal ranks in the top quartile (Q1) amongst its peers in Microbiology, and Q2 in the field of Molecular Biology, demonstrating its significance and relevance through Scopus rankings—specifically, it holds the #42 spot out of 182 in the Microbiology category and #108 out of 410 in Molecular Biology. With an editorial commitment to advancing the understanding of microbial and molecular sciences, mSphere provides an accessible platform for researchers, professionals, and students alike to disseminate groundbreaking findings. The journal promotes rigorous peer-review and invites innovative contributions aimed at enhancing microbial research mobility and molecular exploration. Accessible openly since 2016, mSphere continues to thrive as an influential publication driving scientific dialogue and discovery in the microbiological sciences.
CRITICAL REVIEWS IN MICROBIOLOGY
Synthesizing Expertise for a Deeper UnderstandingCRITICAL REVIEWS IN MICROBIOLOGY, published by Taylor & Francis Ltd, is a leading peer-reviewed journal that has made significant contributions to the field of microbiology since its inception in 1971. With a prestigious Q1 ranking in Applied Microbiology and Biotechnology, as well as in Medicine and Microbiology, this journal is recognized for its high-quality reviews that synthesize current research and emerging trends in the discipline. Researchers and professionals rely on its comprehensive evaluations and critical insights, helping to advance knowledge and application in various microbiological contexts. Although the journal does not currently operate under an open access model, it remains an invaluable resource for academics seeking to stay at the forefront of microbiological advances. With a consistent publication record, CRITICAL REVIEWS IN MICROBIOLOGY continues to support the scholarly community by addressing key issues and innovations within the field.
Infection and Drug Resistance
Empowering researchers with vital knowledge in pharmacology.Infection and Drug Resistance, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to the critical fields of infectious diseases and pharmacology. Since its establishment in 2008, this journal has emerged as a vital resource for researchers, professionals, and students alike, offering thorough insights into the mechanisms of drug resistance and the effectiveness of various therapeutic interventions. With an impressive 2023 impact factor placing it in the Q2 category across multiple relevant disciplines, including Infectious Diseases and Pharmacology, it serves as a significant platform for high-quality research dissemination. Infection and Drug Resistance aims to foster a deeper understanding of the evolving challenges in managing infectious diseases and enhancing drug efficacy, contributing to the global discourse on public health. The journal's commitment to open access ensures that vital knowledge is readily available to promote broader scholarly engagement and innovation.
BRAZILIAN JOURNAL OF MICROBIOLOGY
Championing Open Access to Microbial DiscoveriesThe BRAZILIAN JOURNAL OF MICROBIOLOGY, published by SPRINGER, stands as a pivotal platform in the field of microbiology, offering an open access model since 2000. With the ISSN 1517-8382 and E-ISSN 1678-4405, this esteemed journal encourages the dissemination of groundbreaking research and innovative methodologies that contribute to the understanding of microbial life, its role in health and disease, and its environmental impact. Based in Switzerland and accessible globally, the journal’s categorization in the Q3 quartile for Microbiology reflects its commitment to quality and relevance in the scientific community. As of 2023, it ranks 121 out of 182 in the Scopus listings for Microbiology, further highlighting its growing influence in immunology and microbiological research. With converged years spanning from 1992 to 2024, the journal continues to support a diverse range of studies, making it an invaluable resource for researchers, professionals, and students alike.
International Journal of Antimicrobial Agents
Pioneering Insights into Antimicrobial Efficacy and SafetyInternational Journal of Antimicrobial Agents, published by Elsevier, stands as a premier platform in the fields of Infectious Diseases, Microbiology, and Medical Pharmacology. With an impressive impact factor and ranked in the Q1 category across multiple medical disciplines in 2023, this journal is recognized for its contribution to advancing knowledge and understanding in the efficacy and safety of antimicrobial treatments. Its comprehensive scope from 1991 to 2024 allows for the publishing of original research, reviews, and commentary on pressing issues related to antimicrobial resistance, treatment strategies, and pharmacological innovations. With a strong emphasis on high-quality research as reflected in its Scopus rankings, the journal is an essential resource for researchers, clinicians, and students dedicated to improving patient outcomes in the face of evolving microbiological challenges. Engage with the latest findings and methodologies through this vital academic resource, available in print and online, from the heart of the Netherlands.
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
Pioneering Discoveries in Food Safety and QualityINTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY is a leading journal in the field of food safety and microbiology, published by Elsevier. With an impressive impact factor and a distinguished position, it ranks in the top quartile for both Food Science and Medicine, as well as holding a strong presence in Microbiology and Safety, Risk, Reliability, and Quality categories. The journal provides a vital platform for researchers, professionals, and students to disseminate and discuss innovative research findings and applications that address the complexities of food microbiology. Operating from its headquarters in the Netherlands, this journal not only facilitates access to high-quality scholarly articles but also encourages the development of interdisciplinary approaches to tackle current challenges in food safety and public health. Since its inception in 1984, the journal has continually evolved, ensuring that it remains at the forefront of scientific inquiry, making it a crucial resource for anyone engaged in the food sciences.